Clinical study for target control infusion system with processed EEG
Clinical study for target control infusion system with processed EEG
批准号:
08457398
负责人:
MATSUKI Akitomo
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
研究了催眠终点和/或处理的EEG变量,如双谱指数(BIS)、95%谱边缘频率(95% sef)和中位数频率(MF),以监测全静脉(i.v)麻醉期间的麻醉(催眠)深度。在本研究中,研究了异丙酚(SY.+-)作用下无语言命令反应(UVC)、睫毛反射丧失(LER)和身体运动对机械鼻膜刺激(简称NBMR)的催眠终点与BIS、95% SEF和MF之间的关系。[]芬太尼静脉麻醉。42例患者随机分配接受丙泊酚输注30 mg kg<@D1-1@>D1h<@D1-1@>D1 (P,n=22)或丙泊酚输注30 mg kg<@D1-1@>D1h<@D1-1@>D1+芬太尼丸,2mug kg<@D1-1@>D1 iv (PE,n=20)。监测BIS、95% SEF、MF和异丙酚剂量,并记录UVC、LER和NBMR抑制作用(INBMR)。与P组相比,PF组的BIS值显著高于P组,即74.7(]SY.+- - [)10.9,73.1(]SY.+- -[)10.5和47.1(]SY.+- - [)9.2 vs.65.8(]SY.+-。[9.8, 59.6] SY。+ -。在UVC、LER和INBMR上分别为[)10和33.8(]SY.+- .[)5.7。与P组相比,PF组实现催眠终点的异丙酚剂量显著降低。与P组相比,PF组INBMR时血浆丙泊酚浓度较低(9.2(]SY.+- . [)2.0 mug ml<@D1-1@>D1; 14.1(]SY.+- . [)4.2mug ml<@D1-1@>D1)。我们的研究结果表明,芬太尼预处理增强了异丙酚的作用,并在较高的BIS值和较低的异丙酚剂量和浓度(以INBMR测量)下达到催眠终点,并且BIS依赖于监测麻醉深度的麻醉方案。
英文摘要
Hypnotic endpoints and/or processed EEG variables, e.g., bispectral index (BIS), 95% spectral edge frequency (95%SEF)and median frequency (MF) have been studied to monitor anaessthetic (hypnosis) depth during total intravenous (i.v.) anaesthesia. In this study, the relationship between the hypnotic endpoints of unresponsiveness to verbal commands (UVC), loss of eyelash reflex (LER) and body movement response to mechanical nasal membrane stimulation (abbreviated as NBMR) vs. BIS,95% SEF and MF during propofol(]SY.+-。[)fentanyl i.v.anaesthesia is presented. Forty-two patients were randomly assigned to receive either propofol infusion, 30 mg kg<@D1-1@>D1h<@D1-1@>D1 (P,n=22) or propofol infusion, 30 mg kg<@D1-1@>D1h<@D1-1@>D1+fentanyl bolus, 2mug kg<@D1-1@>D1 iv. (PE,n=20). BIS,95% SEF and MF and propofol doses were monitored and recorded at UVC,LER and inhibition of NBMR (INBMR). The BIS values were significantly higher in the PF as compared to the P group, i.e., 74.7(]SY.+-。[)10.9,73.1(]SY.+-。[)10.5 and 47.1(]SY.+-。[)9.2 vs.65.8(]SY.+-。[)9.8,59.6(]SY.+-。[)10 and 33.8(]SY.+-。[)5.7 at UVC,LER and INBMR,respectively. Doses of propofol for achieving the hypnotic endpoints were significantly lower in the PF group as comparedto the P group. Plasma propofol concentrations at INBMR were lower in the PF as compared to the P group (9.2(]SY.+-。[)2.0 mug ml<@D1-1@>D1 ys.14.1(]SY.+-。[)4.2mug ml<@D1-1@>D1). Our results suggest that fentanyl pretreatment potentiates the effects of propofol and achieves the hypnotic endpoints at higher BIS values and lower propofoldoses and concentrations (measured at INBMR) and that the BIS is dependent on the anaesthetic regimen for monitoring the depth of anaesthesia.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A Matsuki, H Ishihara: Clinical aspect of total intravenous anesthesia. Kokuseido, 211 (1997)
A Matsuki、H Ishihara:全静脉麻醉的临床方面。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
坂井哲博: "プロポフォール、フェンタニル、ケタミンを用いた全静脈麻酔を行い、麻酔薬の薬物動態を追跡できた乳児症例" 麻酔. 47・3. 314-317 (1998)
Tetsuhiro Sakai:“使用丙泊酚、芬太尼和氯胺酮进行全静脉麻醉的婴儿病例,可以追踪麻醉药的药代动力学”47·3(1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
WD Mi, et al: "Haemodynamic and electroencephalograph responses to intubation during induction with propofol orpropofol/fentanyl" Can J Anaesth. 45. 19-22 (1998)
WD Mi 等人:“丙泊酚或丙泊酚/芬太尼诱导期间插管的血流动力学和脑电图反应”Can J Anaesth。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuki A: "Clinieal study on total intravenous anesthesia with droperidol,fentanyl and ketamine,1.Introduction." Jpn Anesth. 39(9). 1206-1212 (1990)
松木A:“氟哌利多、芬太尼和氯胺酮全静脉麻醉的临床研究,1.简介。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
坂井 哲博 他: "全静脈麻酔のcomponentとしてのケタミンの役割" Pharmacoanesthesiology. 10. 110-112 (1997)
Tetsuhiro Sakai 等人:“氯胺酮作为全静脉麻醉成分的作用”《药物麻醉学》10. 110-112 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
A study on the mechanism of General Anesthesia-inuduced sleep-relation to endogenous sleep related substances
-
批准号:13671560
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:2001
-
负责人:MATSUKI Akitomo
-
依托单位:
Pharmacokinetic study for target controlled infusion of ketamine and fentanyl
-
批准号:05454412
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.62万
-
财政年份:1993
-
负责人:MATSUKI Akitomo
-
依托单位:
国内基金
海外基金
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: